We found that TMBIM1 interacts with Rab9a, localizing within lysosomes, which promotes the degradation of TGFBR1 and inhibits the TGF-β signaling pathway, thereby reducing CS and preventing HCC. The gene discussed is TGFBR1; the disease is hepatocellular carcinoma.